Altered prion protein expression pattern in CSF as a biomarker for creutzfeldt-jakob disease

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Torres, Mauricio ^a,b   Cartier, Luis ^a   Matamala, José Manuel ^a,b   Hernández, Nancy ^a,b   Woehlbier, Ute ^a,b   Hetz, Claudio ^a,b,c,d  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c Harvard School of Public Health ^*  (Chile)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; PRION PROTEIN; PROTEIN 14 3 3; PROTEINASE; BIOLOGICAL MARKER;

ADULT; ARTICLE; AUTOPSY; BRAIN NERVE CELL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; TROPICAL SPASTIC PARAPARESIS; UPREGULATION; BRAIN; ENZYMOLOGY; GENE EXPRESSION REGULATION; GLYCOSYLATION; METABOLISM; MIDDLE AGED; PRION;

14-3-3 PROTEINS; BIOLOGICAL MARKERS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; PRIONS; UP-REGULATION;

EID: 84860428854     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036159     Document Type: Article

References (47)

1. Soto C, (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4: 49-60.
2. Tuite MF, Serio TR, The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 11: 823-833.
3. Soto C, Prion hypothesis: the end of the controversy? Trends Biochem Sci 36: 151-158.
4. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, et al. (2005) Diagnosis of human prion disease. Proc Natl Acad Sci U S A 102: 3501-3506.
5. Westermark GT, Westermark P, Prion-like aggregates: infectious agents in human disease. Trends Mol Med 16: 501-507.
6. Prusiner SB, (1998) Prions. Proc Natl Acad Sci U S A 95: 13363-13383.
7. Galvez S, Cartier L, (1987) [Clinical analysis of a series of 69 definitive cases of Jakob-Creutzfeldt disease occurring in Chile between 1960 and 1985]. Rev Med Chil 115: 1148-1154.
8. Brown P, Galvez S, Goldfarb LG, Nieto A, Cartier L, et al. (1992) Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J Neurol Sci 112: 65-67.
9. Prusiner SB, Hsiao KK, (1994) Human prion diseases. Ann Neurol 35: 385-395.
10. Poser S, Mollenhauer B, Kraubeta A, Zerr I, Steinhoff BJ, et al. (1999) How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 122 (Pt 12): 2345-2351.
11. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, et al. (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5: 459-466.
12. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J, (1996) Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 53: 913-920.
13. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG, (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335: 924-930.
14. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, et al. (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43: 32-40.
15. Beaudry P, Cohen P, Brandel JP, Delasnerie-Laupretre N, Richard S, et al. (1999) 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 10: 40-46.
16. Lemstra AW, van Meegen MT, Vreyling JP, Meijerink PH, Jansen GH, et al. (2000) 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients. Neurology 55: 514-516.
17. Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF, (2001) CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 56: 1528-1533.
18. Chapman T, McKeel DW Jr, Morris JC, (2000) Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology 55: 1396-1397.
19. Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, et al. (2003) Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 60: 813-816.
20. Zerr I, Poser S, (2002) Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS 110: 88-98.
21. Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, et al. (2000) Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci U S A 97: 5468-5473.
22. Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, et al. (2011) Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377: 487-493.
23. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, et al. (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17: 175-178.
24. Tagliavini F, Prelli F, Porro M, Salmona M, Bugiani O, et al. (1992) A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun 184: 1398-1404.
25. Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, et al. (2009) Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 17: 863-873.
26. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, et al. (2008) Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 416: 297-305.
27. Wong BS, Green AJ, Li R, Xie Z, Pan T, et al. (2001) Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol 194: 9-14.
28. Watt NT, Hooper NM, (2005) Reactive oxygen species (ROS)-mediated beta-cleavage of the prion protein in the mechanism of the cellular response to oxidative stress. Biochem Soc Trans 33: 1123-1125.
29. Chen S, Mange A, Dong L, Lehmann S, Schachner M, (2003) Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 22: 227-233.
30. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, et al. (2000) Signal transduction through prion protein. Science 289: 1925-1928.
31. Castellani RJ, Colucci M, Xie Z, Zou W, Li C, et al. (2004) Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 63: 436-442.
32. Huang N, Marie SK, Livramento JA, Chammas R, Nitrini R, (2003) 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Neurology 61: 354-357.
33. Berg D, Holzmann C, Riess O, (2003) 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4: 752-762.
34. Jones DH, Martin H, Madrazo J, Robinson KA, Nielsen P, et al. (1995) Expression and structural analysis of 14-3-3 proteins. J Mol Biol 245: 375-384.
35. Baxter HC, Liu WG, Forster JL, Aitken A, Fraser JR, (2002) Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 109: 5-14.
36. Martin H, Rostas J, Patel Y, Aitken A, (1994) Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 63: 2259-2265.
37. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, et al. (1994) Activation of Raf-1 by 14-3-3 proteins. Nature 371: 612-614.
38. Wiltfang J, Otto M, Baxter HC, Bodemer M, Steinacker P, et al. (1999) Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem 73: 2485-2490.
39. Hetz CA, Soto C, (2006) Stressing out the ER: a role of the unfolded protein response in prion-related disorders. Curr Mol Med 6: 37-43.
40. Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C, (2003) Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 22: 5435-5445.
41. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, et al. (2005) The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 25: 2793-2802.
42. Torres M, Castillo K, Armisen R, Stutzin A, Soto C, et al. Prion protein misfolding affects calcium homeostasis and sensitizes cells to endoplasmic reticulum stress. PLoS One 5: e15658.
43. Russelakis-Carneiro M, Hetz C, Maundrell K, Soto C, (2004) Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. Am J Pathol 165: 1839-1848.
44. Stahl N, Borchelt DR, Hsiao K, Prusiner SB, (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51: 229-240.
45. De Castro-Costa CM, Araujo AQ, Barreto MM, Takayanagui OM, Sohler MP, et al. (2006) Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (HAM/TSP). AIDS Res Hum Retroviruses 22: 931-935.
46. Hetz C, Bernasconi P, Fisher J, Lee AH, Bassik MC, et al. (2006) Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 312: 572-576.
47. Hetz C, Castilla J, Soto C, (2007) Perturbation of endoplasmic reticulum homeostasis facilitates prion replication. J Biol Chem 282: 12725-12733.